Wasson steers Walgreens in new directions
which Wasson’s three immediate predecessors often referred to as a “crawl, walk, run company”
Opinion
Retail pharmacy has place in the big leagues
The annual Fortune 500 listing of the largest publicly traded U.S. corporations has been published, and community pharmacy, while not a major presence, is nonetheless adequately represented.
Understanding the riddle of Rx compliance
Medication adherence has emerged as a hot-button issue in health care.
Merck Adherence Estimator demonstrates worth
The Adherence Estimator, a patient segmentation tool developed by researchers at Merck & Co. to help pharmacists and other health care professionals identify and assist individuals prone to medication nonadherence, has proved its worth in a variety of practice settings since its debut last year.
CVS, Home Depot get help from Ken’s Krew
Sometime in the middle years of the 1990s, Ken Langone, a cofounder of Home Depot Inc. who has since become a legendary figure in U.S.
Tom Ryan: An example for others to follow
The Ryan Years” [in the May 23 issue] brought to mind an occasion five years ago when my wife and I, with our children in tow, set off one evening for a welcoming reception at the NACDS Annual Meeting. We were arriving early, but not for professional reasons.
NACDS Annual Meeting reflects industry’s vitality
The National Association of Chain Drug Stores made two giant leaps forward last month, further distancing itself from every other retail trade organization in the United States.
The area where independents have an edge
One of the most interesting phenomena in retail pharmacy is the continued vitality of independent drug stores.
An exceptional Annual Meeting unfolds
for a variety of reasons not connected to the program or the current issues facing the association or the chain drug industry. More specifically: • The 2011 NACDS Annual Meeting marks the last
New climate in Washington will test pharmacy
Once again a fellow named Ryan is shaking up the retail pharmacy business. With his proposed federal spending plan for fiscal 2012, Rep. Paul Ryan (R., Wis.
National and store brands learn how to coexist
Even before the current recession, consumers began to put pressure on national brand manufacturers by positioning store brand products as the value alternative to branded products. It is well documented that consumers are now more accepting of less expensive quality alternatives to national brands.
Walgreens, CVS are taking divergent paths
In the immediate aftermath of Walgreens’ announced purchase of drugstore.com, the burning questions of the moment in mass retailing are these: Is a drug store a retail outlet or a health care provider? Or can it be both? Clearly, Walgreens is buying drugstore.
CVS Caremark aims to heighten impact on Rx
When Larry Merlo became chief executive officer of CVS Caremark Corp. last month he made it clear that his top priority is to realize the full potential of the integrated pharmacy care model that has decisively shaped the evolution of the company in recent years.
Walgreens’ uniting of Magnacca, Pugh a brilliant stroke
In a stunning announcement out of Deerfield, Ill., earlier this month Walgreen Co.
Retail/PBM Rx model still holds promise
Walgreens’ decision to sell its pharmacy benefits management business to Catalyst Health Solutions for $525 million is sure to intensify the debate about whether drug chains are well served by owning and operating such entities. For Walgreens, at least, the answer is clearly no.
Ryan ends transformative tenure at CVS
when, at age 42, he became only the third CEO in the history of a retailer that began business as a